Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
J.VollsetS
Limited recent data exist on prescribing patterns and patient characteristics for GLP-1 RA medications, whether used as anti-diabetic medication (ADM) for patients with type 2 diabetes (T2D) and/or used as an anti-obesity medication (AOM) for patients with overweight or obesity
The potential causes of this heterogeneity mainly include population characteristics, drug specificity, the intensity of lifestyle intervention, and the impact of comorbidities [50]
Reconstitution errors, dose escalation mistakes, and timing misjudgments account for the majority of failed protocols
Red flags requiring urgent evaluation include hematemesis, intractable vomiting leading to dehydration, severe abdominal pain or distention, and signs of gastrointestinal bleeding
US$ 22.22
US$ 24.36
US$ 29.48
US$ 21.15
US$ 21.73
US$ 28.01
